Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30184
A New blaVIM Gene in a Pseudomonas putida Isolated from ENT Units in Sulaimani Hospitals

Authors: Dalanya Asaad Mohammed, Dara Abdul Razaq

Abstract:

A total of twenty tensile biopsies were collected from children undergoing tonsillectomy from teaching hospital ENT department and Kurdistan private hospital in sulaimani city. All biopsies were homogenized and cultured; the obtained bacterial isolates were purified and identified by biochemical tests and VITEK 2 compact system. Among the twenty studied samples, only one Pseudomonas putida with probability of 99% was isolated. Antimicrobial susceptibility was carried out by disk diffusion method, Pseudomonas putida showed resistance to all antibiotics used except vancomycin. The isolate further subjected to PCR and DNA sequence analysis of blaVIM gene using different set of primers for different regions of VIM gene. The results were found to be PCR positive for the blaVIM gene. To determine the sequence of blaVIM gene, DNA sequencing performed. Sequence alignment of blaVIM gene with previously recorded blaVIM gene in NCBI- database showed that P. putida isolate have different blaVIM gene.

Keywords: Clinical isolates, Putida, Sulaimani, Vim gene.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1082879

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1277

References:


[1] Allen, L. H., Herman, G.T. and Friedman, F.H. (2002). Staphylococcus aureus Infection and Disease. Kluwer Academic Publishers. New York, Boston, Dordrecht, London, Moscow.
[2] Dervisoglue, E., Dundar, D.O., Yegenaga, I., Willke, A.( 2007) Peritonitis due to Pseudomonas putida in a Patient Receiving Automated Peritoneal Dialysis". Infection.
[3] Jeong, S. H., Lee, K., Chong, Y. et al. (2003). Characterization of a new integron containing VIM-2, a metallo-ß-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. Journal of Antimicrobial Chemotherapy 51, 397-400.
[4] Koh,T.H., Wang,G.C. and Sng,L.H.2004 IMP-1 and a novel metallobeta- lactamase, VIM-6, in fluorescent pseudomonads isolated in Singapore
[5] Lawrence, M. and Tierniy, J. (1999). Medical diagnosis and treatment. 38th Ed. California. San Francisco. California. USA.
[6] Lee K., Jong Back Lim, Jong Hwa Yum, 2002 blaVIM-2 Cassette- Containing Novel Integrons in Metallo-β-Lactamase-Producing Pseudomonas aeruginosa and Pseudomonas putida Isolates Disseminated in a Korean Hospital, Antimicrob Agents Chemother. April; 46(4): 1053-1058.
[7] Luzzaro, F., Docquier, J. D., Colinon, C. et al. (2004). Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-ß-lactamase encoded by a conjugative plasmid. Antimicrobial Agents and Chemotherapy 48, 648-50.
[8] Otenio, M.H., Da Silva, M.T.L., Marques, M.L.O, Roseiro, J.C., Bidoia, E.D. (2005) "Benzene, Toluene, and Xylene Biodegradation by Pseudomonas putida CCMI 852". Brazilian Journal of Microbiology. P. 258-261.
[9] Patzer,J.A., Walsh,T.R., Weeks,J., Dzierzanowska,D. and Toleman,M.A. 2009. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, Antimicrob. Chemother. 63 (2), 269-273.
[10] Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J D, Nordmann P. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β- lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000;44:891-897.
[11] Poirel, K. Ludovic Cabanne, Louis Collet, and Patrice Nordmann(2006)Class II Transposon-Borne Structure Harboring Metallo-_-Lactamase ,Gene blaVIM-2 in Pseudomonas putida.Antimicrobial Agents And Chemotherapy, p. 2889-2891.
[12] Papadopoulou,C., Thisiadou,K., Sofianou,D. and Siarkou,V.I.2007.blaVIM-1 metallo-beta-lactamase gene in Pseudomonas putida clinical isolates. J of microbiology and infectious disease,vol 4, 118.
[13] Rasmussen, B. A., Bush, K., Keeney, D. et al. (1996). Characterization of IMI-1 ß-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 40, 2080-6.
[14] Riccio M L, Franceschini N, Boschi L, Caravelli B, Cornaglia G, Fontana R, Amicosante G, Rossolini G M.(2000) Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother;44:1229-1235
[15] Sachie Yomoda, Toyoji Okubo, Ayako Takahashi, Masami Murakami, and Shizuko Iyobe(2003) Presence of Pseudomonas putida Strains Harboring Plasmids Bearing the Metallo-_-Lactamase Gene blaIMP in a Hospital in Japan ,Journal Of Clinical Microbiology, p. 4246-4251
[16] Santos,C., Caetano,T., Ferreira,S. and Mendo,S. 2008. J. Biology, University of Aveiro, Campus Santiago, Aveiro 3810, Portugal
[17] Siarkou,V.I., Papadopoulou,C., Thisiadou,K. and Sofianou,2007. JOURNAL Submitted Laboratory of Microbiology and Infectious Diseases, Faculty of Veterinary Medicine, Aristotle University of Thessaloniki, University Campus, Thessaloniki 54124, Greece
[18] Yan, J. J., Ko, W. W., Chuang, C. L. et al. (2005). Metallo-ß-lactamaseproducing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. Journal of Antimicrobial Chemotherapy 50, 503-11.
[19] Yum,J.H., Choi,Y., Park,D.-Y., Yong,D., Lee,K. and hong,Y.2005.Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, 134 Shinchondong, Seodaemungu, Seoul 120-752,Korea.